Endologix Inc (ELGX) Inventory Turnover Ratio, from second quarter 2020 to second quarter 2019, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Endologix Inc  (ELGX)
 

Endologix Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2020, Endologix Inc's inventory turnover ratio sequentially decreased to 1.88 in the second quarter 2020, unsurprisingly, as the Endologix Inc markets continue to deteriorate, and ELGX's faces growing challenges to bring down its inventories. Endologix Inc's average inventory processing period in the Jun 30 2020 quarter, has increased to 194 days, from 193 days, in the Mar 31 2020 quarter.

Within Healthcare sector 253 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the II Quarter 2020, to 1688, from total ranking in the first quarter 2020 at 1691.

ELGX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Endologix Inc Market Share?

What is Inventory Turnover Ratio?




ELGX Inventory Turnover Ratio (Jun 30 2020)
II. Quarter
(Mar 31 2020)
I. Quarter
(Dec 31 2019)
IV. Quarter
(Sep 30 2019)
III. Quarter
(Jun 30 2019)
II. Quarter
Y / Y Inventory Growth -15.74 % -18.93 % -13.14 % -26.93 % -28.16 %
Y / Y Cost of Sales Growth -19.36 % 7.83 % -40.32 % 4.72 % -12.43 %
Inventory Turnover Ratio (TTM) 1.88 1.89 1.77 2.02 1.83
ELGX's Total Ranking # 1688 # 1691 # 1691 # 1689 # 1423
Average inventory processing period 194 193 206 181 199
Seq. Inventory Growth 5.81 % -7.27 % -14.48 % 0.42 % 1.8 %
Seq. Cost of Sales Growth -20.11 % -3.91 % 9.61 % -4.17 % 6.83 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 102
Healthcare Sector # 254
Overall Market # 1688

Inventory Turnover Ratio Statistics
High Average Low
3.53 2.35 1.2
(Dec 31 2013)   (Jun 30 2012)




Financial Statements
Endologix Inc's Inventories $ 26 Millions Visit ELGX's Balance sheet
Endologix Inc's Cost of Revenues TTM $ 51 Millions Visit ELGX's Income Statement
What are ELGX's Sales? Visit ELGX's Sales by Segment

Other Inventory Turnover Ratios
Endologix Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ELGX's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ELGX's Competitors
Inventory Turnover Ratio for ELGX's Suppliers
Inventory Turnover Ratio for ELGX's Customers

You may also want to know
ELGX's Sales Growth Rates ELGX's Pe Price to earnings ratio ELGX's Receivables Turnover Ratio ELGX's Stock Quote
ELGX's Net Income Growth Rates ELGX's Ps Price to Sales ratio ELGX's Sales per Employee ELGX's Asset Turnover Ratio
ELGX's Net Margin ELGX's Pb Price to Book ratio ELGX's Financial Strength Ratios ELGX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2020, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2020 Inventories at quarter ending Jun 30 2020
Patterson Companies Inc   5.36 $ 4,246.025  Millions$ 792  Millions
Myriad Genetics Inc   5.28 $ 157.500  Millions$ 30  Millions
Camp4 Therapeutics Corporation  5.27 $ 213.771  Millions$ 41  Millions
Vericel Corporation  5.25 $ 38.491  Millions$ 7  Millions
Orgenesis Inc   5.23 $ 3.002  Millions$ 1  Millions
West Pharmaceutical Services Inc   5.17 $ 1,282.300  Millions$ 248  Millions
Hill rom Holdings Inc   5.12 $ 1,454.500  Millions$ 284  Millions
Inogen Inc   5.09 $ 182.506  Millions$ 36  Millions
Grapefruit Usa Inc   5.07 $ 1.434  Millions$ 0  Millions
Idexx Laboratories Inc  5.06 $ 1,063.875  Millions$ 210  Millions
Adm Tronics Unlimited Inc   5.03 $ 1.917  Millions$ 0  Millions
Gw Pharmaceuticals Plc  5.03 $ 34.925  Millions$ 7  Millions
Mallinckrodt Plc  4.99 $ 1,619.900  Millions$ 324  Millions
Sintx Technologies Inc   4.99 $ 0.668  Millions$ 0  Millions
Gilead Sciences Inc   4.95 $ 4,751.000  Millions$ 961  Millions
Invacare Holdings Corporation  4.93 $ 628.243  Millions$ 127  Millions
Henry Schein Inc   4.72 $ 6,518.880  Millions$ 1,380  Millions
Alimera Sciences Inc  4.69 $ 7.264  Millions$ 2  Millions
Eagle Pharmaceuticals inc   4.68 $ 35.240  Millions$ 8  Millions
Htg Molecular Diagnostics Inc  4.63 $ 6.348  Millions$ 1  Millions
Endo International Plc  4.58 $ 1,514.116  Millions$ 330  Millions
Neuronetics Inc   4.55 $ 13.545  Millions$ 3  Millions
Dexcom Inc   4.52 $ 619.200  Millions$ 137  Millions
Integrated Biopharma Inc  4.50 $ 46.042  Millions$ 10  Millions
Prophase Labs Inc   4.45 $ 7.890  Millions$ 2  Millions
Cytosorbents Corporation  4.41 $ 9.426  Millions$ 2  Millions
National Vision Holdings Inc   4.37 $ 532.824  Millions$ 122  Millions
Mimedx Group Inc   4.31 $ 44.137  Millions$ 10  Millions
Harrow Inc   4.26 $ 14.456  Millions$ 3  Millions
Exact Sciences Corporation  4.23 $ 282.673  Millions$ 67  Millions

Date modified: 2026-09-08T15:10:01+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.